Author
Listed:
- Shingo Nakahata
(University of Miyazaki, 5200 Kihara, Kiyotake)
- Tomonaga Ichikawa
(University of Miyazaki, 5200 Kihara, Kiyotake)
- Phudit Maneesaay
(University of Miyazaki, Nishi 1-1, Gakuen Kibana Dai)
- Yusuke Saito
(University of Miyazaki, 5200 Kihara, Kiyotake)
- Kentaro Nagai
(University of Miyazaki, 5200 Kihara, Kiyotake)
- Tomohiro Tamura
(University of Miyazaki, 5200 Kihara, Kiyotake)
- Nawin Manachai
(University of Miyazaki, 5200 Kihara, Kiyotake)
- Norio Yamakawa
(University of Miyazaki, 5200 Kihara, Kiyotake)
- Makoto Hamasaki
(University of Miyazaki, 5200 Kihara, Kiyotake)
- Issay Kitabayashi
(National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku)
- Yasuhito Arai
(National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku)
- Yae Kanai
(National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku)
- Tomohiko Taki
(Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku)
- Takaya Abe
(Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Developmental Biology, 2-2-3 Minatojima-minamimachi, Chuo-ku, Kobe)
- Hiroshi Kiyonari
(Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Developmental Biology, 2-2-3 Minatojima-minamimachi, Chuo-ku, Kobe)
- Kazuya Shimoda
(University of Miyazaki, 5200 Kihara, Kiyotake)
- Koichi Ohshima
(School of Medicine, Kurume University, 67 Asahimati)
- Akira Horii
(Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku)
- Hiroshi Shima
(Miyagi Cancer Center Research Institute, 47-1 Nodayama, Medeshima-Shiode)
- Masafumi Taniwaki
(Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku)
- Ryoji Yamaguchi
(University of Miyazaki, Nishi 1-1, Gakuen Kibana Dai)
- Kazuhiro Morishita
(University of Miyazaki, 5200 Kihara, Kiyotake)
Abstract
Constitutive phosphatidylinositol 3-kinase (PI3K)-AKT activation has a causal role in adult T-cell leukaemia-lymphoma (ATLL) and other cancers. ATLL cells do not harbour genetic alterations in PTEN and PI3KCA but express high levels of PTEN that is highly phosphorylated at its C-terminal tail. Here we report a mechanism for the N-myc downstream-regulated gene 2 (NDRG2)-dependent regulation of PTEN phosphatase activity via the dephosphorylation of PTEN at the Ser380, Thr382 and Thr383 cluster within the C-terminal tail. We show that NDRG2 is a PTEN-binding protein that recruits protein phosphatase 2A (PP2A) to PTEN. The expression of NDRG2 is frequently downregulated in ATLL, resulting in enhanced phosphorylation of PTEN at the Ser380/Thr382/Thr383 cluster and enhanced activation of the PI3K-AKT pathway. Given the high incidence of T-cell lymphoma and other cancers in NDRG2-deficient mice, PI3K-AKT activation via enhanced PTEN phosphorylation may be critical for the development of cancer.
Suggested Citation
Shingo Nakahata & Tomonaga Ichikawa & Phudit Maneesaay & Yusuke Saito & Kentaro Nagai & Tomohiro Tamura & Nawin Manachai & Norio Yamakawa & Makoto Hamasaki & Issay Kitabayashi & Yasuhito Arai & Yae Ka, 2014.
"Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers,"
Nature Communications, Nature, vol. 5(1), pages 1-15, May.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4393
DOI: 10.1038/ncomms4393
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4393. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.